How have KWBT shares performed in 2024?

Kiwa Bio-Tech Products Group's stock was trading at $0.0002 on January 1st, 2024. Since then, KWBT stock has increased by 0.0% and is now trading at $0.0002. View the best growth stocks for 2024 here .

How were Kiwa Bio-Tech Products Group's earnings last quarter?

Kiwa Bio-Tech Products Group Co. (OTCMKTS:KWBT) issued its quarterly earnings data on Tuesday, November, 20th. The company reported $0.04 EPS for the quarter. The firm had revenue of $7.73 million for the quarter.

What other stocks do shareholders of Kiwa Bio-Tech Products Group own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Kiwa Bio-Tech Products Group investors own include Co-Diagnostics (CODX) , BioRestorative Therapies (BRTX) , FuelCell Energy (FCEL) , iBio (IBIO) , SANUWAVE Health (SNWV) , Sierra Oncology (SRRA) , Tonix Pharmaceuticals (TNXP) , Aurora Cannabis (ACB) and Ascent Solar Technologies (ASTI) .

How do I buy shares of Kiwa Bio-Tech Products Group?

Shares of KWBT stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here .

OTCMKTS:KWBT

Kiwa Bio-Tech Products Group (KWBT) Stock Price, News & Analysis

→ This company has increased its dividend every year for 54 years (From DTI) (Ad)

Free KWBT Stock Alerts

$0.0002

0.00 (0.00%)

(As of 09/25/2023)

Compare

Today's Range: $0.0002
▼
$0.0002
50-Day Range: N/A
52-Week Range: $0.0001
▼
$0.0010

Volume: 2,600 shs
Average Volume: N/A
Market Capitalization: N/A

P/E Ratio: N/A
Dividend Yield: N/A
Price Target: N/A

Stock Analysis

Get Kiwa Bio-Tech Products Group alerts:

Ad Paradigm Press

Bitcoin Rockets To Record High But Buy THIS Instead

Recently, Bitcoin smashed through its previous record high to hit $72,720. It’s made many, many people very rich. But one cryptocurrency expert and investing millionaire is declaring…

>>Click here to find out what it is.

About Kiwa Bio-Tech Products Group Stock (OTCMKTS:KWBT)

Kiwa Bio-Tech Products Group Corporation, together with its subsidiaries, develops, manufactures, markets, and distributes bio-technological products for the agricultural market primarily in the People's Republic of China. It offers bacillus species and/or photosynthetic bacteria based biological organic, compound microbial, bio-water soluble, and microbial inoculum fertilizers. The company has a strategic cooperation agreements with the Beijing Zhongpin Agricultural Science and Technology Development Center; China Academy of Agricultural Science's Institute of Agricultural Resources & Regional Planning; and Institute of Agricultural Economy & Development, as well as Kiwa Bio-Tech (Yangling) Co. Ltd. Kiwa Bio-Tech Products Group Corporation was founded in 2002 and is headquartered in Yangling, China.

KWBT Stock Price History

30 days | 90 days | 365 days | Advanced Chart

KWBT Stock News Headlines

March 18, 2024 | markets.businessinsider.com

Dupharma Biotech forms R&D partnerships for new therapies

February 15, 2024 | realmoney.thestreet.com

One Small Biotech and Cannabis Are on My Mind as Market Laggards Fight Back

April 18, 2024 | Darwin (Ad)

Your Next Portfolio Star: Revealing 2024's Top Stock Pick

We're thrilled to offer you an exclusive look at the #1 Buy & Hold Stock of 2024. This isn't just any report. It's the culmination of rigorous analysis, expert insights, and cutting-edge financial strategies, distilled into a compelling narrative that charts the course of what we believe to be the year's most promising investment. (**By clicking the link you are subscribing to The Wealth Creation Investing Newsletter and may receive up to 2 additional free bonus subscriptions. Unsubscribing is easy.)

January 22, 2024 | bizjournals.com

Canada's largest biotech acquires Gaithersburg firm

January 9, 2024 | investing.com

Chenguang Biotech Group (300138)

January 5, 2024 | finanznachrichten.de

Shelly Group: Shelly Set to Launch Next Generation Products at CES 2024

January 5, 2024 | msn.com

US biotech company halts sales of DNA kits in Tibet, as lawmakers mull more export controls on China

July 1, 2023 | techrepublic.com

Top Products

April 18, 2024 | Darwin (Ad)

Your Next Portfolio Star: Revealing 2024's Top Stock Pick

June 28, 2023 | techrepublic.com

Support for these Microsoft enterprise products ends in 2023

June 13, 2023 | wsj.com

Shenzhen Agricultural Products Group Co. Ltd. A

May 15, 2023 | investing.com

Financial Products Group Co Ltd (7148)

March 10, 2023 | reuters.com

Cash is king in biotech M&A, but will clinical data be a saving grace?

October 3, 2022 | finance.yahoo.com

New Partners to Restructure KIWA

October 3, 2022 | finance.yahoo.com

New Partners to Restructure KIWA

September 24, 2022 | marketwatch.com

PHBI Pharmagreen Biotech Appoints Ethan Styles as Vice President of Product Research and Development

September 17, 2022 | benzinga.com

BioChain is officially a 10X Visium Certified Service Provider for spatial multiomics products and services

September 13, 2022 | benzinga.com

Kessler Topaz Meltzer & Check, LLP: Announces Securities Fraud Class Action Lawsuit Filed against Kiromic BioPharma, Inc.

September 13, 2022 | washingtonpost.com

Business Highlights: Twitter whistleblower, biotech push

September 8, 2022 | benzinga.com

The Gross Law Firm Announces Class Actions on Behalf of Shareholders of NIO, LTCH and ABT

August 17, 2022 | benzinga.com

Kasada Named One of Australia's Best Workplaces by Great Place to Work®

August 17, 2022 | msn.com

Needham Maintains Buy Rating for I-MAB: Here's What You Need To Know

August 15, 2022 | benzinga.com

Mitsubishi Tanabe Pharma America Announces Real-World Data Analysis of Survival with RADICAVA® (edaravone)

August 15, 2022 | yahoo.com

Black Bird Biotech Management Affirms Long-Term Commitment, Exchanges One-Third, over 120 Million, of Outstanding Common Shares for Preferred Shares

August 5, 2022 | benzinga.com

Kibo Releases Subscriptions Management To Help Retailers Boost Revenue and Customer Loyalty

August 5, 2022 | benzinga.com

Tebra Named on Top 100 Healthcare Technology Companies of 2022

August 1, 2022 | benzinga.com

BioIVT Announces Promotion of Dr. Richard Haigh to CEO

See More Headlines

Receive KWBT Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Kiwa Bio-Tech Products Group and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings: 11/20/2018
Today: 4/18/2024
Fiscal Year End: 12/31/2024

Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange: OTCMKTS
Sector: Basic Materials
Industry: Agricultural chemicals
Sub-Industry: N/A
Current Symbol: OTCMKTS:KWBT
CUSIP: N/A
CIK: 1159275
Web: www.kiwabiotech.com
Phone: (909) 456-8828
Fax: 626-626-7665
Employees: 16
Year Founded: N/A

Profitability

EPS (Most Recent Fiscal Year): N/A
Trailing P/E Ratio: N/A
Forward P/E Ratio: N/A
P/E Growth: N/A
Net Income: N/A
Net Margins: N/A
Pretax Margin: N/A
Return on Equity: N/A
Return on Assets: N/A

Debt

Debt-to-Equity Ratio: N/A
Current Ratio: N/A
Quick Ratio: N/A

Sales & Book Value

Annual Sales: N/A
Price / Sales: N/A
Cash Flow: N/A
Price / Cash Flow: N/A
Book Value: N/A
Price / Book: N/A

Miscellaneous

Outstanding Shares: N/A
Free Float: N/A
Market Cap: N/A
Optionable: Not Optionable
Beta: 1.97

Elon Musk's Next Move

Wondering when you'll finally be able to invest in SpaceX, StarLink, or The Boring Company? Click the link below to learn when Elon Musk will let these companies finally IPO.

Get This Free Report

Key Executives

Ms. Ziqi Wang
Chief Exec. Officer
Mr. Chaozhao Zhao
Exec. Pres & GM of Mining Bus. Department
Mr. Sen Yang
Chief Financial Officer
Mr. Boyu Liu
Chief Operating Officer
Mr. Dadong Li
Exec. VP
Mr. Mingzheng Bao
CAO & CPO
Prof. Qi Wang (Age 57)
Director

Key Competitors

View All Competitors

KWBT Stock Analysis - Frequently Asked Questions

How have KWBT shares performed in 2024?: Kiwa Bio-Tech Products Group's stock was trading at $0.0002 on January 1st, 2024. Since then, KWBT stock has increased by 0.0% and is now trading at $0.0002.
View the best growth stocks for 2024 here.
How were Kiwa Bio-Tech Products Group's earnings last quarter?: Kiwa Bio-Tech Products Group Co. (OTCMKTS:KWBT) issued its quarterly earnings data on Tuesday, November, 20th. The company reported $0.04 EPS for the quarter. The firm had revenue of $7.73 million for the quarter.
What other stocks do shareholders of Kiwa Bio-Tech Products Group own?: Based on aggregate information from My MarketBeat watchlists, some companies that other Kiwa Bio-Tech Products Group investors own include Co-Diagnostics (CODX), BioRestorative Therapies (BRTX), FuelCell Energy (FCEL), iBio (IBIO), SANUWAVE Health (SNWV), Sierra Oncology (SRRA), Tonix Pharmaceuticals (TNXP), Aurora Cannabis (ACB) and Ascent Solar Technologies (ASTI).
How do I buy shares of Kiwa Bio-Tech Products Group?: Shares of KWBT stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (OTCMKTS:KWBT) was last updated on 4/18/2024 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial